Biomaxima (BMX) - Total Liabilities

Latest as of September 2025: zł30.50 Million PLN ≈ $8.39 Million USD

Based on the latest financial reports, Biomaxima (BMX) has total liabilities worth zł30.50 Million PLN (≈ $8.39 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Biomaxima (BMX) cash conversion ratio to assess how effectively this company generates cash.

Biomaxima - Total Liabilities Trend (2009–2024)

This chart illustrates how Biomaxima's total liabilities have evolved over time, based on quarterly financial data. Check Biomaxima liquidity resilience to evaluate the company's liquid asset resilience ratio.

Biomaxima Competitors by Total Liabilities

The table below lists competitors of Biomaxima ranked by their total liabilities.

Company	Country	Total Liabilities
Wise Group AB ST:WISE	Sweden	Skr132.58 Million
Malpac Holdings Bhd KLSE:4936	Malaysia	RM8.95 Million
Aurora Spine Corp V:ASG	Canada	CA$7.86 Million
17 Education Technology Group Inc NASDAQ:YQ	USA	$148.36 Million
Powerhouse Ventures Ltd AU:PVL	Australia	AU$2.05 Million
Nidaros Sparebank OL:NISB	Norway	Nkr4.41 Billion
Melewar Industrial Group Bhd KLSE:3778	Malaysia	RM181.72 Million
East Asia Holdings Investment Limited KQ:900110	Korea	₩15.77 Billion

Liability Composition Analysis (2009–2024)

This chart breaks down Biomaxima's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Biomaxima (BMX) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.41	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.39	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biomaxima's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biomaxima (2009–2024)

The table below shows the annual total liabilities of Biomaxima from 2009 to 2024.

Year	Total Liabilities	Change
2024-12-31	zł29.01 Million ≈ $7.98 Million	+8.21%
2023-12-31	zł26.81 Million ≈ $7.38 Million	+22.05%
2022-12-31	zł21.96 Million ≈ $6.05 Million	-32.90%
2021-12-31	zł32.74 Million ≈ $9.01 Million	+19.08%
2020-12-31	zł27.49 Million ≈ $7.57 Million	+2.42%
2019-12-31	zł26.84 Million ≈ $7.39 Million	-1.01%
2018-12-31	zł27.11 Million ≈ $7.46 Million	+173.06%
2017-12-31	zł9.93 Million ≈ $2.73 Million	+50.85%
2016-12-31	zł6.58 Million ≈ $1.81 Million	+4.07%
2015-12-31	zł6.33 Million ≈ $1.74 Million	-8.73%
2014-12-31	zł6.93 Million ≈ $1.91 Million	-15.73%
2013-12-31	zł8.22 Million ≈ $2.26 Million	+24.03%
2012-12-31	zł6.63 Million ≈ $1.82 Million	+25.67%
2011-12-31	zł5.28 Million ≈ $1.45 Million	+39.96%
2010-12-31	zł3.77 Million ≈ $1.04 Million	+48.18%
2009-12-31	zł2.54 Million ≈ $700.15K	--

About Biomaxima

WAR:BMX Poland Diagnostics & Research

Market Cap

$13.55 Million

zł49.23 Million PLN

Market Cap Rank

#26114 Global

#275 in Poland

Share Price

zł11.74

Change (1 day)

+0.69%

52-Week Range

zł10.90 - zł15.30

All Time High

zł55.45